Sergio Traversa | executive |
Maged Shenouda | executive |
Basma Radwan Ibrahim | analyst |
Andrew Cutler | executive |
Andrea Tan | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics, Inc.
First Quarter 2024 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, May 8, 2024. I would now like to turn the conference over to Tim McCarthy, LifeSci Advisors. Please go ahead.